Fluorouracil alone can cause a variety of dermatologic adverse effects; however, it is not considered to be a chemical vesicant. We report a case of apparent enhanced local skin reaction from the combination of intravenous fluorouracil and leucovorin. The reaction occurred in the patient's other hand on rechallenge.
CurranCFLuceJK. Fluorouracil and palmar-plantar erythrodysesthesia (letter). Ann Inn Med1989; 111: 858.
3.
Package insert. Fluorouracil. Franklin Park, IL: SoloPak Laboratories, 1989 July.
4.
GremJLHothDFHamiltonJMKingSALeyland-JonesB. Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid. Cancer Treat Rep1987; 71: 1249–64.
TetaJBO'ConnorL. Local tissue damage from 5-fluorouracil extravasation (letter). Oncol Nurs Forum1984; 11: 77.
7.
ArbuckSG. Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer1989; 63: 1036–44.
8.
O'ConnellMJ. A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. Cancer1989; 63: 1026–30.
9.
MerlanoMBacigalupoABenassoM, 5-Fluorouracil and high-dose folinic acid as second-line chemotherapy in head and neck cancer. Am J Clin Oncol1990; 13: 1–3.
